Physician profile
Chris Amro
NPI 1326660853
$8,050.48
in general payments reported to CMS, 2019-2025
14 companies · $5,579 in 2025
The $5,579 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2023: $73.36 · 2024: $2,271 · 2025: $5,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,970 · Travel and Lodging: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,969.75 |
| Travel and Lodging | $953.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $4,200.16 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $1,049.18 | 2025 | Phasix Mesh, Arista, Surgiphor |
| Axogen | $619.76 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Abbvie INC. | $439.46 | 2024-2025 | |
| Kerecis Limited | $385.11 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Becton, Dickinson and Company | $359.34 | 2024 | Phasix Mesh |
| Tela Bio, INC. | $200.95 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Polynovo North America LLC | $170.08 | 2024 | Novosorb Btm |
| Solventum Corporation | $150.00 | 2025 | V.A.C.Ulta |
| Depuy Synthes Sales INC. | $144.31 | 2025 | Na |
| Penumbra, INC. | $126.91 | 2022 | |
| Endo USA, INC. | $125.00 | 2024 | Xiaflex |
| Medical Device Business Services, INC. | $40.59 | 2025 | Va-Lcp |
| Smith+Nephew, INC. | $39.63 | 2024 | Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Amro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.